Literature DB >> 25708933

Revisiting phage therapy: new applications for old resources.

Franklin L Nobrega1, Ana Rita Costa1, Leon D Kluskens1, Joana Azeredo2.   

Abstract

The success of phage therapy is dependent on the development of strategies able to overcome the limitations of bacteriophages as therapeutic agents, the creation of an adequate regulatory framework, the implementation of safety protocols, and acceptance by the general public. Many approaches have been proposed to circumvent phages' intrinsic limitations but none have proved to be completely satisfactory. In this review we present the major hurdles of phage therapy and the solutions proposed to circumvent them. A thorough discussion of the advantages and drawbacks of these solutions is provided and special attention is given to the genetic modification of phages as an achievable strategy to shape bacteriophages to exhibit desirable biological properties.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Keywords:  bacteriophages; genetic modification; phage therapy; recombineering

Mesh:

Year:  2015        PMID: 25708933     DOI: 10.1016/j.tim.2015.01.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  90 in total

Review 1.  Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins.

Authors:  Ning Jia; Dinshaw J Patel
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-04       Impact factor: 94.444

2.  Bacterial Endospores as Phage Genome Carriers and Protective Shells.

Authors:  Naiana Gabiatti; Pingfeng Yu; Jacques Mathieu; Grant W Lu; Xifan Wang; Hangjun Zhang; Hugo M Soares; Pedro J J Alvarez
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

Review 3.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

Review 4.  Shaping of cutaneous function by encounters with commensals.

Authors:  Emma Barnard; Huiying Li
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

Review 5.  Phage Therapy in the Era of Synthetic Biology.

Authors:  E Magda Barbu; Kyle C Cady; Bolyn Hubby
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

6.  Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.

Authors:  Alan R Hauser; Joan Mecsas; Donald T Moir
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

Review 7.  Biofilm control with natural and genetically-modified phages.

Authors:  Amir Mohaghegh Motlagh; Ananda Shankar Bhattacharjee; Ramesh Goel
Journal:  World J Microbiol Biotechnol       Date:  2016-03-01       Impact factor: 3.312

8.  Mutant and Recombinant Phages Selected from In Vitro Coevolution Conditions Overcome Phage-Resistant Listeria monocytogenes.

Authors:  Tracey Lee Peters; Yaxiong Song; Daniel W Bryan; Lauren K Hudson; Thomas G Denes
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

9.  An Insight into Phage Diversity at Environmental Habitats using Comparative Metagenomics Approach.

Authors:  Krupa Parmar; Nishant Dafale; Rajesh Pal; Hitesh Tikariha; Hemant Purohit
Journal:  Curr Microbiol       Date:  2017-09-19       Impact factor: 2.188

10.  Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria.

Authors:  Samuel Kilcher; Patrick Studer; Christina Muessner; Jochen Klumpp; Martin J Loessner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.